☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Engage
The US FDA's Advisory Panel Slams Biogen's Aducanumab for Alzheimer's Disease
November 9, 2020
PharmaShots' Key Highlights of First Quarter 2019
August 4, 2019
Biogen and Eisai Terminate P-III ENGAGE and EMERGE Study for Alzheimer's Disease
March 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
